MARINARI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.277
EU - Europa 340
AS - Asia 102
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 2.731
Nazione #
US - Stati Uniti d'America 2.277
CN - Cina 74
UA - Ucraina 69
DE - Germania 56
IE - Irlanda 49
IT - Italia 42
SE - Svezia 32
GB - Regno Unito 30
FR - Francia 25
FI - Finlandia 11
KR - Corea 11
RU - Federazione Russa 10
IN - India 7
PL - Polonia 7
JP - Giappone 5
AU - Australia 3
EU - Europa 3
BE - Belgio 2
KG - Kirghizistan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
Totale 2.731
Città #
Houston 413
Wilmington 395
Woodbridge 382
Chandler 191
Ann Arbor 180
Fairfield 155
Ashburn 70
Seattle 63
Jacksonville 56
Cambridge 49
Dublin 49
Medford 40
New York 36
Beijing 33
Dearborn 31
Lawrence 19
Rome 19
Zhengzhou 10
Mülheim 9
Boardman 7
Falls Church 7
San Diego 7
Kraków 6
Pune 6
Saint Louis 6
Kunming 5
San Mateo 5
Guangzhou 4
Jinan 4
Menlo Park 4
Mountain View 3
Norwalk 3
Redwood City 3
Santa Maria Nuova 3
Shanghai 3
Brussels 2
Crema 2
Guidonia Montecelio 2
Hefei 2
Hounslow 2
Kilburn 2
London 2
Milan 2
Nanjing 2
Nürnberg 2
St Helens 2
Wuhan 2
Auburn Hills 1
Auckland 1
Bari 1
Boston 1
Chisinau 1
Clearwater 1
Cupertino 1
Esslingen am Neckar 1
Haifa 1
Lima 1
Logan 1
Los Angeles 1
Melbourne 1
Nanchang 1
Nanning 1
Pilis 1
Quito 1
Quzhou 1
Redmond 1
Rock Hill 1
Scottsdale 1
Seoul 1
Shenyang 1
Southend 1
São Paulo 1
University Park 1
Vienna 1
Yellow Springs 1
Totale 2.328
Nome #
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 404
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 399
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 261
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 257
Claudin-1 is a p63 target gene with a crucial role in epithelial development 149
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 141
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 136
p63 induces key target genes required for epidermal morphogenesis 116
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 110
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters 99
RelA/NF-kappa B recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 98
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 90
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 86
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 86
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 85
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 83
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome 75
Genetic markers predictive of clinical response to biological drugs in psoriasis. 74
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 35
Totale 2.784
Categoria #
all - tutte 7.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019190 0 0 0 0 0 0 0 0 0 43 72 75
2019/2020753 49 37 45 75 59 88 88 75 61 92 36 48
2020/2021447 29 59 43 57 31 38 59 41 23 22 33 12
2021/2022209 3 18 15 10 9 16 5 14 11 26 17 65
2022/2023378 37 42 33 58 23 74 18 24 41 3 21 4
2023/2024106 18 4 3 3 13 44 4 14 0 3 0 0
Totale 2.784